The secondary endpoints included overall survival, overall response rates, and safety profile.

次要终点包括整个生存期 、 整体反应率和安全情况.

互联网

Results The overall survival rate recovery with function was 85 %.

结果再植后成活率达93%,按断指再植疗效评定标准优良率达85%.

互联网

The five - gene signature was an independent predictor of relapse - free and overall survival.

这五个基因是对无复发和总生存率的独立预测指标.

互联网

The 5 - year overall survival ( OS ) and disease free survival ( DFS ) were 89 % and 73 %, respectively.

全组5年总 生存率 和无病生存率分别为89%和73%.

互联网

Conclusions Our five - gene signature is closely associated with relapse - free and overall survival among patients with NSCLC.

结论:我们的五个基因标记与非小细胞肺癌患者的无复发及总生存率密切相关.

互联网